A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Safety and Efficacy of Fingolimod in MS Patients in China

NCT01941004 ·Status: WITHDRAWN ·Phase: PHASE3

Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients

NCT02809079 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

NCT06697535 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

NCT07182409 ·Status: NOT_YET_RECRUITING

A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

NCT06396039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Safety of Therapeutic Step-down in Neuromyelitis Optica

NCT05155644 ·Status: COMPLETED

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

NCT02021825 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT02073279 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT04660539 ·Status: COMPLETED ·Phase: PHASE3

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

NCT05214794 ·Status: COMPLETED ·Phase: PHASE2

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

NCT05061953 ·Status: RECRUITING

Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

NCT01517282 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05147220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients

NCT04667949 ·Status: COMPLETED ·Phase: PHASE4

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

NCT04372615 ·Status: RECRUITING ·Phase: PHASE2

HANDLE-a Real World Study on Satralizumab in NMOSD

NCT06829524 ·Status: NOT_YET_RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis

NCT05064436 ·Status: TERMINATED ·Phase: PHASE1

A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis

NCT04711148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

NCT04101058 ·Status: UNKNOWN

Safety of Bryostatin in Patients With MS

NCT06190912 ·Status: TERMINATED ·Phase: PHASE1

China National Registry of Neuro-Inflammatory Diseases

NCT05154370 ·Status: RECRUITING

Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis

NCT05116540 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

NCT01199640 ·Status: COMPLETED ·Phase: PHASE2

Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder

NCT07304960 ·Status: NOT_YET_RECRUITING